Bionyra Pharma
Developing next-generation biologics for severe immunological and inflammatory diseases
$165MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Developing next-generation biologics for severe immunological and inflammatory diseases
Develops a novel class of potent and precise antibody therapies to treat a broad range of cancers